Ubichem Fine Chemicals has sold a majority stake in Ubichem Research, which provides chemistry services to drug developers through its Ubichem Pharma Services, to investment group Lochlomond Holding.
The European Union (EU) formally adopted the falsified medicines directive at the weekend, giving member states 18 months to makes the document's anti-counterfeiting track and trace measures into national law.
Watson Pharmaceuticals has bought Greek generics firm Specifar Pharmaceuticals, bringing to an end a busy month of deal making in the non-branded drug sector.
US healthcare giant Baxter has commissioned logistics specialists Gazeley to begin construction on a new distribution warehouse just outside Lyon, France.
Parexel subsidiary and eClinical service provider, Perceptive Informatics, has announced the results of a global survey into site monitoring and management activities during clinical trials.
Quintiles will help South Korea develop its clinical research infrastructure under a new collaboration with the Korea National Enterprise for Clinical trials (KoNECT).
From July the EC will require that gelatin used in parenteral drugs is sourced from countries in World Organisation for Animal Health's (OIE) lowest risk categories for bovine spongiform encephalopathy (BSE).
UK-based contract manufacturing organisation (CMO) SCM Pharma has struck a deal with urology experts Speciality European Pharma (SEP) to help bring SEP's oncology product, Plenaxis, to the European market.
The US Food and Drug Administration (FDA) has published a list of all the drug manufacturing facilities it has inspected between October 2008 and September 2010 as part of Government transparency efforts.
ACRO has welcomed new draft guidance on SAE reporting in trials issued by India's CDSCO, but has raised some concerns about the determination of causality and compensation.
German transdermal drug developer, Labtec, has opened what it claims is Europe’s most modern manufacturing facility for the production of transdermal drug delivery systems (TDS) and oral dispersible films (ODF) using its proprietary RapidFilm technology.
Florida-based contract manufacturing organisation (CMO), Goodwin Biotechnology (GBI), has entered into an agreement with protein and monoclonal antibody drug developer, Rafagen, to provide cell line engineering and biological contract manufacturing services.
Canadian pharmaceutical packaging firm, Ropack, has begun stickpack production in its new state-of-the-art 15,000 sq. ft. dedicated manufacturing suite.
A serialisation system developed by Systech International has been selected by a ‘top 10’ pharma client as a way of meeting Brazil’s Law 11.903 track and trace requirements.
Biologics Process Development, a wholly-owned subsidiary of Californian contract research organisation (CRO), Viropro, has announced it is to double the size of its bioprocess and scale-up laboratory.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Sanofi Pasteur, Klöckner Pentaplast and Geron.
The US Association for the Advancement of Medical Instrumentation (AAMI) has adopted the latest version of the ANSI14155 standards for medical device trials.
Pharma needs to learn from other sectors and abandon the multistage development paradigm in favour of a two-stage design and manufacturing model to cut attrition rates.
The financial flexibility and quality standards of Indian CMOs should be enough to stave off competition from newer global contract manufacturing hubs, according to market research company RNCOS.
Serina Therapeutics has developed a new way of synthesizing polyoxazoline (POZ) polymers for drug delivery applications that, it claims, is free of the drawbacks that have hampered previous production methods.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at RxTrials, BASi, Novella and Premier Research.
SAFC, the custom manufacturing and business services wing of Sigma Aldritch, has announced a licensing agreement with biotech company, Agilent Technologies, for the sale of its nucleic acids synthesis products and technologies.
US contract research organisation (CRO) PRA International claims it intends to “reshape how the industry manages trials” after acquiring Indian eClinical software developer, Kinship Technologies, for an undisclosed amount.
Prefilled injection systems specialist Vetter has completed structural work on its new facility in Erlen, Germany, eleven months after ground-breaking.
Alkermes saw losses increase in fiscal 2011 but has issued an upbeat outlook on higher revenues, portfolio expansion and impending acquisition of Elan Drug Technologies (EDT).
Marketing applications should contain details of clinical trial ethics and be rejected if serious violations are found, said some EMA workshop participants.
Clinical Financial Services (CFS), a US financial management company specialising in clinical trial management, has launched its new Site Activation Services offering, designed to ‘streamline and automate’ the trial activation process.
Californian biotech tool manufacturer Life Technologies has teamed with German contract research organisation (CRO) ProBiogen to release a range of royalty-free Gibco Freedom Cell Line Development Kits.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Aphena, Acino and blue inspection body.